看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 8.6x - 9.5x | 9.1x |
| Selected Fwd Ps Multiple | 8.3x - 9.2x | 8.7x |
| Fair Value | €38.81 - €42.90 | €40.86 |
| Upside | -20.6% - -12.2% | -16.4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Bristol-Myers Squibb Company | - | NYSE:BMY |
| GSK plc | - | PINC:GLAX.F |
| Johnson & Johnson | - | KAS:JNJ_KZ |
| Roche Holding AG | - | PINC:RHHV.F |
| Sanofi | - | SET:SANOFI80 |
| Chugai Pharmaceutical Co., Ltd. | - | DB:CUP |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| BMY | GLAX.F | JNJ_KZ | RHHV.F | SANOFI80 | CUP | |||
| NYSE:BMY | PINC:GLAX.F | KAS:JNJ_KZ | PINC:RHHV.F | SET:SANOFI80 | DB:CUP | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 13.1% | -1.5% | 1.6% | -0.4% | 3.3% | 11.3% | ||
| 3Y CAGR | 1.4% | 8.3% | 4.1% | -1.8% | 4.2% | 5.4% | ||
| Latest Twelve Months | 4.6% | 3.5% | 4.3% | 3.2% | -2.4% | 18.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 1.5% | 24.5% | 24.5% | 21.3% | 18.3% | 29.7% | ||
| Prior Fiscal Year | 17.8% | 16.2% | 15.6% | 19.0% | 12.3% | 29.3% | ||
| Latest Fiscal Year | -18.5% | 8.2% | 15.8% | 13.3% | 12.4% | 33.1% | ||
| Latest Twelve Months | 11.4% | 8.2% | 24.4% | 13.3% | 13.8% | 33.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 7.2x | 8.3x | 12.9x | 10.5x | 10.4x | 20.2x | ||
| Price / LTM Sales | 2.1x | 1.8x | 4.2x | 3.5x | 2.6x | 10.8x | ||
| LTM P/E Ratio | 18.6x | 22.5x | 17.2x | 26.1x | 18.5x | 32.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 1.8x | 2.6x | 4.2x | |||||
| Historical LTM P/S Ratio | 4.8x | 6.9x | 12.0x | |||||
| Selected Price / Sales Multiple | 8.6x | 9.1x | 9.5x | |||||
| (x) LTM Sales | 1,222,121 | 1,222,121 | 1,222,121 | |||||
| (=) Equity Value | 10,531,718 | 11,086,019 | 11,640,320 | |||||
| (/) Shares Outstanding | 1,645.6 | 1,645.6 | 1,645.6 | |||||
| Implied Value Range | 6,399.87 | 6,736.70 | 7,073.54 | |||||
| FX Rate: JPY/EUR | 162.6 | 162.6 | 162.6 | Market Price | ||||
| Implied Value Range (Trading Cur) | 39.36 | 41.43 | 43.50 | 48.87 | ||||
| Upside / (Downside) | -19.5% | -15.2% | -11.0% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | BMY | GLAX.F | JNJ_KZ | RHHV.F | SANOFI80 | CUP | |
| Value of Common Equity | 100,167 | 57,027 | 372,941 | 214,233 | 119,185 | 13,077,815 | |
| (/) Shares Outstanding | 2,035.1 | 4,049.0 | 2,406.1 | 795.4 | 1,236,095.0 | 1,645.6 | |
| Implied Stock Price | 49.22 | 14.08 | 155.00 | 269.34 | 0.10 | 7,947.07 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.75 | 1.00 | 0.83 | 0.03 | 162.62 | |
| Implied Stock Price (Trading Cur) | 49.22 | 18.81 | 155.00 | 326.42 | 3.66 | 48.87 | |
| Trading Currency | USD | USD | USD | USD | THB | EUR | |
| FX Rate to Reporting Currency | 1.00 | 0.75 | 1.00 | 0.83 | 0.03 | 162.62 | |